News Rezvoglar Price Announced March 1, 2023 Read More » Skyclarys February 28, 2023 Read More » Pharmedica USA LLC Issues Voluntary Worldwide Recall of Purely Soothing 15% MSM Drops Due to Non-Sterility February 23, 2023 Read More » Global Pharma Healthcare Issues Voluntary Nationwide Recall of Delsam Pharma Artificial Eye Ointment Due to Possible Microbial Contamination February 23, 2023 Read More » Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance February 22, 2023 Read More » Pozelimab (C5 Antibody) BLA for Treatment of Children and Adults with Ultra-rare CHAPLE Disease Accepted for FDA Priority Review February 21, 2023 Read More » Filspari February 17, 2023 Read More » Altuviiio February 17, 2023 Read More » Lamzede February 16, 2023 Read More » Page1 … Page16 Page17 Page18 Page19 Page20 … Page43 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required) Email(Required) Comment(Required) Company Name(Required) CAPTCHA
Pharmedica USA LLC Issues Voluntary Worldwide Recall of Purely Soothing 15% MSM Drops Due to Non-Sterility February 23, 2023 Read More »
Global Pharma Healthcare Issues Voluntary Nationwide Recall of Delsam Pharma Artificial Eye Ointment Due to Possible Microbial Contamination February 23, 2023 Read More »
Pozelimab (C5 Antibody) BLA for Treatment of Children and Adults with Ultra-rare CHAPLE Disease Accepted for FDA Priority Review February 21, 2023 Read More »